Reproduced from Gaziano JM et al. Randomized clinical trial of quick–release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes. Diabetes Care 2010. Jul;33(7):1503–8. With permission from the American Diabetes Association.